LEXINGTON, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the Rodman & Renshaw 13th Annual Healthcare Conference at 2:25 p.m. EDT on September 12, 2011, in New York City.
